BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22687892)

  • 1. HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirs.
    Fourati S; Lambert-Niclot S; Soulie C; Malet I; Valantin MA; Descours B; Ait-Arkoub Z; Mory B; Carcelain G; Katlama C; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2012 Oct; 67(10):2323-6. PubMed ID: 22687892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals.
    Sanchez G; Xu X; Chermann JC; Hirsch I
    J Virol; 1997 Mar; 71(3):2233-40. PubMed ID: 9032358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients.
    Paolucci S; Baldanti F; Campanini G; Zavattoni M; Cattaneo E; Dossena L; Gerna G
    J Med Virol; 2001 Oct; 65(2):207-17. PubMed ID: 11536225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of APOBEC3-driven mutagenesis on HIV evolution in diverse anatomical compartments.
    Fourati S; Lambert-Niclot S; Soulie C; Wirden M; Malet I; Valantin MA; Tubiana R; Simon A; Katlama C; Carcelain G; Calvez V; Marcelin AG
    AIDS; 2014 Feb; 28(4):487-91. PubMed ID: 24401644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART.
    Monno L; Punzi G; Scarabaggio T; Saracino A; Brindicci G; Fiore JR; Iambrenghi OC; Di Stefano M; Pastore G; Angarano G
    J Med Virol; 2003 May; 70(1):1-9. PubMed ID: 12629636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep molecular characterization of HIV-1 dynamics under suppressive HAART.
    Buzón MJ; Codoñer FM; Frost SD; Pou C; Puertas MC; Massanella M; Dalmau J; Llibre JM; Stevenson M; Blanco J; Clotet B; Paredes R; Martinez-Picado J
    PLoS Pathog; 2011 Oct; 7(10):e1002314. PubMed ID: 22046128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure.
    Fourati S; Malet I; Lambert S; Soulie C; Wirden M; Flandre P; Fofana DB; Sayon S; Simon A; Katlama C; Calvez V; Marcelin AG
    AIDS; 2012 Aug; 26(13):1619-24. PubMed ID: 22695298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut mucosal viral reservoir in HIV-infected patients is not the major source of rebound plasma viremia following interruption of highly active antiretroviral therapy.
    Lerner P; Guadalupe M; Donovan R; Hung J; Flamm J; Prindiville T; Sankaran-Walters S; Syvanen M; Wong JK; George MD; Dandekar S
    J Virol; 2011 May; 85(10):4772-82. PubMed ID: 21345945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers.
    Sharaf R; Lee GQ; Sun X; Etemad B; Aboukhater LM; Hu Z; Brumme ZL; Aga E; Bosch RJ; Wen Y; Namazi G; Gao C; Acosta EP; Gandhi RT; Jacobson JM; Skiest D; Margolis DM; Mitsuyasu R; Volberding P; Connick E; Kuritzkes DR; Lederman MM; Yu XG; Lichterfeld M; Li JZ
    J Clin Invest; 2018 Aug; 128(9):4074-4085. PubMed ID: 30024859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects.
    Anton PA; Mitsuyasu RT; Deeks SG; Scadden DT; Wagner B; Huang C; Macken C; Richman DD; Christopherson C; Borellini F; Lazar R; Hege KM
    AIDS; 2003 Jan; 17(1):53-63. PubMed ID: 12478069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogeny and resistance profiles of HIV-1 POL sequences from rectal biopsies and blood.
    Katzenstein TL; Petersen AB; Storgaard M; Obel N; Jensen-Fangel S; Nielsen C; Jørgensen LB
    J Med Virol; 2010 Jul; 82(7):1103-9. PubMed ID: 20513071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating signs of recent evolution in the pool of proviral HIV type 1 DNA during years of successful HAART.
    Mens H; Pedersen AG; Jørgensen LB; Hue S; Yang Y; Gerstoft J; Katzenstein TL
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):107-15. PubMed ID: 17263640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.
    Otero M; Nunnari G; Leto D; Sullivan J; Wang FX; Frank I; Xu Y; Patel C; Dornadula G; Kulkosky J; Pomerantz RJ
    AIDS Res Hum Retroviruses; 2003 Dec; 19(12):1097-103. PubMed ID: 14709246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART.
    Chew CB; Potter SJ; Wang B; Wang YM; Shaw CO; Dwyer DE; Saksena NK
    J Clin Virol; 2005 Jul; 33(3):206-16. PubMed ID: 15911442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular and cell-free (infectious) HIV-1 in rectal mucosa.
    Di Stefano M; Favia A; Monno L; Lopalco P; Caputi O; Scardigno AC; Pastore G; Fiore JR; Angarano G
    J Med Virol; 2001 Dec; 65(4):637-43. PubMed ID: 11745925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated hypermutation levels in HIV-1 natural viral suppressors.
    Eyzaguirre LM; Charurat M; Redfield RR; Blattner WA; Carr JK; Sajadi MM
    Virology; 2013 Sep; 443(2):306-12. PubMed ID: 23791226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greater diversity of HIV DNA variants in the rectum compared to variants in the blood in patients without HAART.
    Avettand-Fenoel V; Hocqueloux L; Müller-Trutwin M; Prazuck T; Melard A; Chaix ML; Agoute E; Michau C; Rouzioux C
    J Med Virol; 2011 Sep; 83(9):1499-507. PubMed ID: 21739438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
    Hermankova M; Ray SC; Ruff C; Powell-Davis M; Ingersoll R; D'Aquila RT; Quinn TC; Siliciano JD; Siliciano RF; Persaud D
    JAMA; 2001 Jul; 286(2):196-207. PubMed ID: 11448283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of G-to-A mutation frequencies induced by APOBEC3 proteins in H9 cells and peripheral blood mononuclear cells in the context of impaired processivities of drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants.
    Knoepfel SA; Salisch NC; Huelsmann PM; Rauch P; Walter H; Metzner KJ
    J Virol; 2008 Jul; 82(13):6536-45. PubMed ID: 18448538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases.
    Henrich TJ; Hanhauser E; Marty FM; Sirignano MN; Keating S; Lee TH; Robles YP; Davis BT; Li JZ; Heisey A; Hill AL; Busch MP; Armand P; Soiffer RJ; Altfeld M; Kuritzkes DR
    Ann Intern Med; 2014 Sep; 161(5):319-27. PubMed ID: 25047577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.